Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab helped a woman with severe hair loss regrow her hair quickly and maintain it for six months after stopping treatment.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Methotrexate may effectively and safely treat hair loss in children, with notable improvement after 12-15 months.

COVID-19 doesn't make alopecia areata worse.

Minoxidil-dutasteride tattooing can potentially help regrow hair, especially in men who already have some thin hair.

Low vitamin D might be one of several factors involved in the hair loss condition alopecia areata.

Children with autoimmune hair loss have similar vitamin D levels to healthy kids, suggesting no extra screening is needed.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Genetic testing for EGFR mutations is crucial in similar cases.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

A patient with congenital adrenal hyperplasia improved after adjusting her medication to prevent Cushing's syndrome symptoms.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Different conditions affect how hair proteins assemble, and certain mutations can change their structure.

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Topical tofacitinib is effective and safe for treating alopecia areata.

The SbbHLH85 protein helps sweet sorghum grow more root hairs but makes the plant more sensitive to salt.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Researchers created a fast, accurate computer program to measure hair loss in alopecia areata patients.

Higher levels of PD-L1 are linked to more severe hair loss in people with Alopecia Areata.

Baricitinib treatment for severe alopecia areata shows significant improvement by 52 weeks, especially in very severe cases.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

The document explains how to measure sales and marketing success and warns about misusing these measurements.

Cosmetic foam product reduces hair loss and increases hair density in men.

Using rodents for research shows that health problems in the womb can cause diseases later in life.

A man with testotoxicosis was fertile despite low FSH levels, suggesting high testosterone may allow sperm production without FSH.